Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: Implications for the detection of hematogenous prostate cells and standardization

Clinical Chemistry

Volumn 44, Issue 3, 1998, Pages 472-481

  Gala, Jean Luc ^a,b,c   Heusterspreute, Michel ^a,b   Loric, Sylvain ^d   Hanon, France ^a,b   Tombal, Bertrand ^e   Van Cangh, Paul ^e   De Nayer, Philippe ^a,b   Philippe, Marianne ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c QUEEN ASTRID MILITARY HOSPITAL   (Belgium)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; DIAGNOSTIC ACCURACY; DNA DETERMINATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; MALE; PROSTATE CANCER; QUALITY CONTROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0031951878     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.3.472     Document Type: Article

References (30)

1. Oesterling J. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-23.
2. Olsson CA. Reverse transcriptase polymerase chain reaction in prostate cancer. In: Murphy G, Griffiths K, Denis L, Khoury S, Chatelain C, Cockett AT, eds. Proceedings of the First International Consultation in Prostate Cancer. Jersey, UK: Science Communication International, 1997:121-32.
3. Moreno JG, Croce CM, Fischer R, Monne M, Vihko P, Mulholland SG, Gomella LG. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 1992;52:6110-2.
4. Deguchi T, Doi T, Ehara H, Ito S, Takahashi Y, Nishino Y, et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1993;53:5350-4.
5. Katz AE, Olsson CA, Raffo AJ, Cama C, Perlman H, Seaman E, et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 1993;43: 765-75.
6. Olsson CA, De Vries GM, Benson MC, Roffe A, Buttvan R, Cama C, et al. The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancer. Br J Urology 1996;77: 411-7.
7. Ghossein RA, Scher HI, Gerald WL, Kelly WK, Curley T, Amsterdam A, et al. Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J Clin Oncol 1995;13:1195-200.
8. Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, et al. Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 1994;12:2634-9.
9. Israeli RS, Miller WH Jr, Su SL, Powell CT, Fair WR, Samadi DS, et al. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 1994;54:6306-10.
10. Jaakkola S, Vornanen T, Leinonen J, Rannikko S, Stenman UH. Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specifc antigen. Clin Chem 1995;2:182-6.
11. Diamandis EP. Prostate cancer, prostate-specific antigen, and the polymerase chain reaction [Editorial]. CMn Chem 1995;2:177-9.
12. Smith MR, Biggar S, Hussain M. Prostate-specific messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res 1995;55:2640-4.
13. Loric S, Dumas F, Eschwege P, Blanchet P, Benoit G, Jardin A, Lacour B. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. Clin Chem 1995; 12:1698-704.
14. Yu H, Diamandis EP, Zarghami N, Grass L. Induction of prostate specific antigen by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res Treat 1994;32:291-300.
15. Cross NC, Hughes TP, Feng L, O'Shea P, Bungey J, Marks DI, et al. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host-disease and relapse. Br J Haematol 1993;84:67-74.
16. Chelly J, Hugnot JP, Concordet JP, Kaplan JC, Khan A. Illegitimate (or ectopic) transcription proceeds through the usual promoters. Biochem Biophys Res Commun 1991;179:553-7.
17. Heusterspreute M, Kennedy N, Emery S, Ha Thi V, Tournis-Gamble S, Davison J. Restriction site bank vector IV. pJRD184, a 3793 plasmid vector having 43 unique cloning sites Gene 1985;39: 299-304.
18. Zarghami N, Diamandis EP. Detection of prostate-specific antigen mRNA and protein in breast tumors. Clin Chem 1996;3:361-6.
19. Diamandis EP, Yu H. New biological functions of prostate-specific antigen? [Editorial]. J Clin Endocrinol Metab 1995;80:1515-7.
20. Monne M, Croce C, Yu H, Dimandis EP. Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Cancer Res 1994;54:6344-7.
21. Heston WDW. Detection of hematogenous dissemination of prostatic cancer by RT-PCR with primers specific for prostate-specific membrane antigen [Editorial]. Clin Chem 1995;12:1687-8.
22. Galvan B, Christopoulos TK, Diamandis EP. Detection of prostate-specific antigen mRNA by reverse transcription polymerase chain reaction and time-resolved fluorometry. Clin Chem 1995;12: 1705-9.
23. Corey E, Arfman EW, Liu AY, Vessella RL. Improved reverse transcriptase-polymerase chain reaction protocol with exogenous internal competitive control for prostate-specific antigen mRNA in blood and bone marrow. Clin Chem 1997;3:443-52.
24. Lintula S, Stenman UH. The expression of prostate-specific membrane antigen in peripheral blood leukocytes. J Urol 1997;157: 1969-72.
25. Henke W, Jung M, Luin M, Schelte H, Berndt C, Rudolph B, et al. Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood. Int J Cancer 1997;70:52-6.
26. Sarkar G, Sommer S. Access to a messenger sequence or its protein product is not limited by tissue or species specificity. Science 1989;244:331-4.
27. Cooper DN, Berg LP, Kakkar VV, Reiss J. Ectopic (illegitimate) transcription: new possibilities for the analysis and diagnosis of human genetic disease. Ann Med 1994;26:9-14.
28. Mahadevan LC, Edwards DR. Signalling and superinduction. Nature 1991;349:747-8.
29. Herrick D, Parker R, Jacobson A. Identification and comparison of stable and unstable mRNAs in Saccharomyces cerevisiae. Mol Cell Biol 1990;10:2269-84.
30. Jung RJ, Ahmad-Nejad P, Wimmer M, Gerhard M, Wagener C, Neumaier M. Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction.